Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


21.10.2019

2 Clin Infect Dis
1 Gastroenterology
1 Gut
1 Hepatology
2 J Hepatol
1 J Infect Dis
2 J Med Virol
1 J Viral Hepat
1 Lancet Gastroenterol Hepatol
1 Lancet Respir Med
1 PLoS One
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Infect Dis

  1. LIN KY, Lee YL, Huang SH, Chen GJ, et al
    Public health intervention strategies to contain hepatitis A outbreak.
    Clin Infect Dis. 2019 Oct 14. pii: 5586740. doi: 10.1093/cid/ciz1002.
    PubMed     Text format    

  2. MERAT S
    Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial.
    Clin Infect Dis. 2019 Oct 12. pii: 5586681. doi: 10.1093.
    PubMed     Text format    


    Gastroenterology

  3. LAMPERTICO P, Colombo M
    NUCLEOS(T)IDE ANALOG THERAPY OF CHRONIC HEPATITIS B AND LIVER CANCER RISK REDUCTION: BETTER NUCLEOTIDES THAN NUCLEOSIDES?
    Gastroenterology. 2019 Oct 14. pii: S0016-5085(19)41448.
    PubMed     Text format    


    Gut

  4. GAVRIC A, Dezman R, Rankovic B, Ribnikar M, et al
    Nutmeg liver, fever and elevated liver enzymes in a young man.
    Gut. 2019;68:1773-1837.
    PubMed     Text format    


    Hepatology

  5. DANG H, Yeo YH, Yasuda S, Huang CF, et al
    Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West.
    Hepatology. 2019 Oct 14. doi: 10.1002/hep.30988.
    PubMed     Text format     Abstract available


    J Hepatol

  6. SUHAS SOLOMON S, Quinn TC, Solomon S, McFall AM, et al
    Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.
    J Hepatol. 2019 Oct 8. pii: S0168-8278(19)30588.
    PubMed     Text format     Abstract available

  7. MACIAS J
    Reply to: "Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes".
    J Hepatol. 2019 Oct 11. pii: S0168-8278(19)30530.
    PubMed     Text format    


    J Infect Dis

  8. CHIHOTA BV, Wandeler G, Chilengi R, Mulenga L, et al
    High Rates of Hepatitis B Virus (HBV) Functional Cure Among Human Immunodeficiency Virus-HBV Coinfected Patients on Antiretroviral Therapy in Zambia.
    J Infect Dis. 2019 Oct 15. pii: 5581876. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  9. WANG YH, Liao J, Zhang DM, Wu DB, et al
    Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg-positive chronic hepatitis patients with partial virological response to entecavir.
    J Med Virol. 2019 Oct 14. doi: 10.1002/jmv.25608.
    PubMed     Text format     Abstract available

  10. KOC OM, Menart C, Theodore J, Kremer C, et al
    Ethnicity and response to primary three-dose hepatitis B vaccination in employees in the Netherlands, 1983 through 2017.
    J Med Virol. 2019 Oct 17. doi: 10.1002/jmv.25610.
    PubMed     Text format     Abstract available


    J Viral Hepat

  11. DANIEL KE, Saeian K, Rizvi S
    Real-world experiences with direct-acting antiviral agents for chronic hepatitis C treatment.
    J Viral Hepat. 2019 Oct 10. doi: 10.1111/jvh.13218.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  12. ASSELAH T, Loureiro D, Boyer N, Mansouri A, et al
    Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure.
    Lancet Gastroenterol Hepatol. 2019;4:883-892.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  13. CYPEL M, Feld JJ, Galasso M, Pinto Ribeiro RV, et al
    Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Lancet Respir Med. 2019 Oct 9. pii: S2213-2600(19)30268.
    PubMed     Text format     Abstract available


    PLoS One

  14. HANG PHAM TT, Le TX, Nguyen DT, Luu CM, et al
    Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam.
    PLoS One. 2019;14:e0223733.
    PubMed     Text format     Abstract available


    Vaccine

  15. LIU Z, Behloul N, Baha S, Wei W, et al
    Design and immunogenicity analysis of the combined vaccine against zoonotic hepatitis E and foot-and-mouth disease.
    Vaccine. 2019 Oct 8. pii: S0264-410X(19)31245.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: